 Shares of Orthofix Medical NASDAQ:OFIX remained unaffected at 36.16 after the company reported Q1 results.Quarterly Results Earnings per share fell 66.67 over the past year to 0.09, which beat the estimate of 0.06.Revenue of 104,823,000 lower by 3.93 year over year, which missed the estimate of 105,860,000.Looking Ahead Orthofix Medical hasnt issued any earnings guidance for the time being.Orthofix Medical hasnt issued any revenue guidance for the time being.Conference Call Details Date: May 08, 2020View more earnings on OFIXWebcast URL: Action 52-week high: 57.40Companys 52-week low was at 22.11Price action over last quarter: down 1.47Company Description Orthofix Medical Inc is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The company has four reportable segments include Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. It generates maximum revenue from Bone Growth Therapies segment. Geographically, it generates maximum revenue from a company the U.S and also has a presence in Italy, Germany, United Kingdom, Brazil, and other countries.See more from Benzinga Harsco: Q1 Earnings Insights Recap: Mersana Therapeutics Q1 Earnings Noble Midstream Partners: Q1 Earnings InsightsC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 